Intensity Therapeutics
INTS
#9335
Rank
NZ$76.75 M
Marketcap
$5.57
Share price
-2.95%
Change (1 day)
18.59%
Change (1 year)

P/E ratio for Intensity Therapeutics (INTS)

P/E ratio as of November 2024 (TTM): -1.50

According to Intensity Therapeutics's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.49931.

P/E ratio history for Intensity Therapeutics from 2023 to 2023

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.